S&P 500 7,738 +5.76% Nasdaq 26,482 +8.34% Dow Jones 54,509 +5.65% FTSE 100 10,888 -0.18% DAX 26,126 +2.62% Nikkei 225 66,300 +7.17% Hang Seng 25,916 +0.42% WTI Crude 75.53 -10.79% Gold 4,301 +6.23% US 10-Year Treasury Yield 4.635 -0.60% S&P 500 7,738 +5.76% Nasdaq 26,482 +8.34% Dow Jones 54,509 +5.65% FTSE 100 10,888 -0.18% DAX 26,126 +2.62% Nikkei 225 66,300 +7.17% Hang Seng 25,916 +0.42% WTI Crude 75.53 -10.79% Gold 4,301 +6.23% US 10-Year Treasury Yield 4.635 -0.60%

LATEST

Google chief scientist Jeff Dean leaving in AI reshuffle after 27 years at company●SpaceX's lockup expiry tomorrow could trigger record insider selling: 'We're in uncharted waters'●Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook●Amazon says it will share $600 million in Trump tariff refunds with some of its customers — will you get a payout?●SpaceX’s own ambitions just became Rocket Lab’s opportunity●7 Dividend Stocks You Must Buy Immediately to Get Paid in August●The Shai-Hulud npm worm didn't fake its security check — it earned a legitimate one●‘If Clarity Dies, Democrats Killed It’: Lummis Urges Senate to Act on Crypto Bill Before Recess●Google chief scientist Jeff Dean leaving in AI reshuffle after 27 years at company●SpaceX's lockup expiry tomorrow could trigger record insider selling: 'We're in uncharted waters'●Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook●Amazon says it will share $600 million in Trump tariff refunds with some of its customers — will you get a payout?●SpaceX’s own ambitions just became Rocket Lab’s opportunity●7 Dividend Stocks You Must Buy Immediately to Get Paid in August●The Shai-Hulud npm worm didn't fake its security check — it earned a legitimate one●‘If Clarity Dies, Democrats Killed It’: Lummis Urges Senate to Act on Crypto Bill Before Recess●

Markets

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic

MarketBeat News Feed · 6h ago · 🇺🇸 United States

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook ahead of Q2 earnings.

Read the full story at MarketBeat News Feed →

More Markets

SpaceX’s own ambitions just became Rocket Lab’s opportunity

TST (Full) - (Official Feed) · 42m ago

17-year-old Mexican restaurant chain closes all locations

TST (Full) - (Official Feed) · 1h ago

Kellogg is bringing a major change to your favorite cereals

TST (Full) - (Official Feed) · 1h ago

Nairobi eyes Canadian mortgages now that barrier to entry is lower

TST (Full) - (Official Feed) · 1h ago